Publication Cover
Redox Report
Communications in Free Radical Research
Volume 7, 2002 - Issue 3
679
Views
25
CrossRef citations to date
0
Altmetric
Research Articles

Catecholamine effects on cardiac remodelling, oxidative stress and fibrosis in experimental heart failure

, , , , , & show all
Pages 145-151 | Published online: 19 Jul 2013

  • The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (consensus). N Engl J Med 1987; 316: 1429–1435.
  • The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685–691.
  • Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Clinical effect of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998; 98: 1184–1191.
  • The CIBIS II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (C1BIS 11): a randomized trial. Lancet 1999; 353: 9–13.
  • Anon. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001–2007.
  • Dhalla KS, Rupp H, Beamish RE, Dhalla NS. Mechanisms of alteration in cardiac membrane Ca' transport due to excess catecholamines. Cardiovasc Drugs Ther 1996; 10: 231–238.
  • Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol1996; 148: 291-300.
  • Dhalla KS, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996;28: 506–514.
  • Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982; 51: 787–801.
  • Wu CF, Bishopric NH, Pratt RE. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 1997;272: 14860–14866.
  • Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 1998; 98: 1329–1334.
  • Iwai-Kanai E, Hasegawa K, Araki M, Katika T, Morimoto T, Sasayama S. Alpha and beta-adrenergic pathways differentially regulate cell type specific apoptosis in rat cardiac myocytes. Circulation 1999; 100: 305–311.
  • Pfeffer MA, Pfeffer JM, Fishbein MC et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979; 44: 503–512.
  • Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212–216.
  • De Haan JB, Newman JD, Kola I. Cu/Zn superoxide dismutase mRNA and enzyme activity, and susceptibility to lipid peroxidation, increases with aging in murine brains. Mol Brain Res 1992; 13: 179–187.
  • Paglia DE, Valentine WN. Studies of the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158–169.
  • Yue T, Cheng H, Lysko PG et al. Carvedilol, a new vasodilator and beta adrenoreceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992; 263: 92–98.
  • Berlin I, Said S, Spreux-Varoquaux 0, Olivares R, Launay JM, Puech AJ. Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry 1995;38: 756–761.
  • Mansuy P. Mougenot N, Ramirez-Gil JF et al. Effects of prolonged propranolol treatment on left ventricular remodelling and oxidative stress after myocardial infarction in rats. J Cardiovasc Pharmacol 2000; 35: 806–813.
  • Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. P-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol 1998;275: H961–H968.
  • McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J1993; 14: 1493-1498.
  • Diaz-Velez CR, Garcia-Castineiras S, Mendoza-Ramos E, Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J1995; 131: 146-152.
  • Remiao F, Carmo H, Carvalho FD, Bastos MI. Inhibition of glutathione reductase by isoproterenol oxidation products. J Enzyme Inhib 2000; 15: 47–61.
  • Wagner KD, Geil D, Schimke I et al. Decreased susceptibility of contractile function to hypoxia/reoxygenation in chronic infarcted rat hearts. J Mol Cell Cardiol 1998; 30: 2341–2353.
  • Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997; 96: 2414–2420.
  • Schieffer B, Wirger A, Meybrunn M et al. Comparative effects of chronic angiotensin-converting enzyme inhibition on angiotensin II type 1 receptor blockade on cardiac remodelling after myocardial infarction in the rat. Circulation 1994; 89: 2273–2282.
  • Cioca DP, Watanabe N, Isobe M. Apoptosis of peripheral blood lymphocytes is induced by catecholamines. Jpn Heart J 2000; 41: 385–398.
  • Zaugg M, Xu W, Lucchinetti E, Shafiq SA, Jamali NZ, Siddiqui MA. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 2000; 102: 344–350.
  • Singh K, Communal C, Sawyer DB, Colucci WS. Adrenergic regulation of myocardial apoptosis. Cardiovasc Res 2000; 45: 713–719.
  • Henaff M, Hatem SN, Mercadier JJ. Low catecholamine concentrations protect adult rat ventricular myocytes against apoptosis through cAMP-dependent extracellular signal-regulated kinase activation. Mol Pharmacol 2000; 58: 1546–1553.
  • Qin F, Rounds NK, Mao W, Kawai K,Liang C-S. Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets. Cadiovasc Res 2031; 51:736-748.
  • Bristow MR, Ginsburg R, Umans V et al. Beta 1 and beta 2 adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective 01 receptor down regulation in heart failure. Circ Res 1986; 59: 297–309.
  • Neumann J, Schmitz W, Scholz H, von Meyerinck L, Doring V, Kalmar P. Increase in myocardial Grproteins in heart failure. Lancet 1988;2: 936–937.
  • Böhm M, La Rose K, Schwinger RHG, Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 1995;25: 146–153.
  • Schwartz DD, Naff BP. Activation of protein kinase C by angiotensin II decreases Pradrenergic receptor responsiveness in the rat heart. J Cardiovasc Pharmacol 1997; 29: 257–264.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.